Education
About Us
Working with TipRanks
Follow Us
Hologic (HOLX)
:HOLX
HOLX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$51.90 - $84.67
Previous CloseN/A
Volume386.02K
Average Volume (3M)1.84M
Market Cap
$15.08B
Enterprise Value$15.30B
Total Cash (Recent Filing)$1.88B
Total Debt (Recent Filing)$2.52B
Price to Earnings (P/E)27.8
Beta0.14
Next Earnings
Nov 03, 2025EPS Estimate
1.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.08
Shares Outstanding222,419,280
10 Day Avg. Volume1,789,856
30 Day Avg. Volume1,841,408
Financial Highlights & Ratios
PEG Ratio0.30
Price to Book (P/B)3.71
Price to Sales (P/S)4.73
P/FCF Ratio16.64
Enterprise Value/Market Cap1.01
Enterprise Value/Revenue3.79
Enterprise Value/Gross Profit7.31
Enterprise Value/Ebitda15.19
Forecast
1Y Price Target
$73.33Price Target Upside8.12% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe company delivered better than expected growth in molecular diagnostics, leading to a slight increase in organizational guidance and earnings per share estimates.
Revenue And EarningsHologic's fiscal third-quarter results were above the high end of key guidance expectations, signaling potential for reaccelerating revenue and earnings growth.
ValuationShares are trading at 15 times next-twelve-month earnings, below the 10-year average, suggesting room for multiple expansion and share price increase.
Bears Say
Market ChallengesManagement is addressing issues in Breast Health, but a softer capital expenditure environment and emerging tariff and funding challenges present a difficult path forward.
Revenue GrowthHOLX's organic ex-COVID sales growth slowed to (1.7%) Y/Y in F3Q25 from (0.7%) Y/Y in F2Q25.
Sales PerformanceSales in China have decreased significantly, and HIV testing revenue is declining faster than anticipated due to broader funding cuts.
Hologic News
HOLX FAQ
What was Hologic’s price range in the past 12 months?
Hologic lowest stock price was $51.90 and its highest was $84.67 in the past 12 months.
What is Hologic’s market cap?
Hologic’s market cap is $15.08B.
When is Hologic’s upcoming earnings report date?
Hologic’s upcoming earnings report date is Nov 03, 2025 which is in 87 days.
How were Hologic’s earnings last quarter?
Hologic released its earnings results on Jul 30, 2025. The company reported $1.08 earnings per share for the quarter, beating the consensus estimate of $1.064 by $0.016.
Is Hologic overvalued?
According to Wall Street analysts Hologic’s price is currently Undervalued.
Does Hologic pay dividends?
Hologic does not currently pay dividends.
What is Hologic’s EPS estimate?
Hologic’s EPS estimate is 1.1.
How many shares outstanding does Hologic have?
Hologic has 222,419,280 shares outstanding.
What happened to Hologic’s price movement after its last earnings report?
Hologic reported an EPS of $1.08 in its last earnings report, beating expectations of $1.064. Following the earnings report the stock price went up 2.832%.
Which hedge fund is a major shareholder of Hologic?
Currently, no hedge funds are holding shares in HOLX
Hologic Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$73.33 (8.12% Upside)
$73.33 (8.12% Upside)
Blogger Sentiment
Bullish
HOLX Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 16.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $300.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 3.8%
Last 30 Days ▼ 3.8%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-18.87%
12-Months-Change
Fundamentals
Return on Equity
11.38%
Trailing 12-Months
Asset Growth
-0.94%
Trailing 12-Months
Company Description
Hologic
Hologic, Inc. (HOLX) is a leading global medical technology company that specializes in women's health. The company develops, manufactures, and supplies diagnostic products, medical imaging systems, and surgical products. Operating primarily in the segments of diagnostics, breast and skeletal health, and gynecological surgical products, Hologic is committed to improving women's health and well-being through innovative medical solutions.
HOLX Company Deck
HOLX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Hologic's earnings call for Q3 FY2025 highlighted strong financial performance with revenue and EPS exceeding expectations. The company showed progress in its Breast Health segment and successful integration of acquisitions like Endomagnetics. However, challenges persist in certain markets like China and Africa, which affected diagnostics growth. Overall, the call reflected optimism for future growth despite some ongoing headwinds.View all HOLX earnings summariesHOLX Revenue Breakdown
44.22% Diagnostics
37.79% Breast Health
15.91% GYN Surgical
2.09% Skeletal Health
HOLX Stock 12 Month Forecast
Average Price Target
$73.33
▲(8.12% Upside)
Technical Analysis
Baxter International
―
Becton Dickinson
―
Cooper Co
―
Resmed
―
West Pharmaceutical Services
―
Ownership Overview
1.34% Insiders
30.52% Mutual Funds
0.79% Other Institutional Investors
38.98% Public Companies and
Individual Investors